1. Home
  2. NBIX vs HII Comparison

NBIX vs HII Comparison

Compare NBIX & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$135.92

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

HOLD

Current Price

$378.06

Market Cap

14.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
HII
Founded
1992
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
14.4B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
HII
Price
$135.92
$378.06
Analyst Decision
Strong Buy
Buy
Analyst Count
21
6
Target Price
$177.29
$329.83
AVG Volume (30 Days)
1.0M
477.6K
Earning Date
02-05-2026
02-05-2026
Dividend Yield
N/A
1.55%
EPS Growth
12.44
N/A
EPS
4.19
14.50
Revenue
$2,682,700,000.00
$12,012,000,000.00
Revenue This Year
$23.68
$5.82
Revenue Next Year
$18.47
$5.37
P/E Ratio
$33.55
$24.59
Revenue Growth
19.61
2.60
52 Week Low
$84.23
$158.88
52 Week High
$160.18
$374.26

Technical Indicators

Market Signals
Indicator
NBIX
HII
Relative Strength Index (RSI) 36.26 70.41
Support Level $134.03 $356.14
Resistance Level $142.16 $360.20
Average True Range (ATR) 3.13 10.12
MACD -1.09 2.18
Stochastic Oscillator 11.91 83.41

Price Performance

Historical Comparison
NBIX
HII

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: